Palavras-chave
Pandemia
Oncologia
Câncer
Sars-Cov-2
Covid 19
Como Citar
Resumo
A pandemia da doença coronavírus 2019 (COVID-19) interrompeu os cuidados de saúde em todo o mundo. Pacientes com câncer parecem ser particularmente suscetíveis às morbidades e mortalidade dessa nova doença. Nenhuma terapia específica para COVID-19 atualmente parece oferecer um benefício de sobrevida para essa população de pacientes. Além disso, os efeitos globais no tratamento de rotina do câncer provavelmente só serão sentidos nas próximas décadas.
Referências
Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).
Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324, 1330–1341 (2020).
Garassino, M. C. et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 21, 914–922 (2020).
Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395, 1907–1918 (2020).
Robilotti, E. V. et al. Determinants of COVID-19 disease severity in patients with cancer. Nat. Med. 26, 1218–1223 (2020).
Tian, J. et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 21, 893–903 (2020).
Mehta, V. et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 10, 935–941 (2020).
Lee, L. Y. W. et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 21, 1309–1316 (2020).
Sharpless, N. E. COVID-19 and cancer. Science 368, 1290 (2020).
Paraguassu, Eber Coelho, et al. "Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and COVID-19." Brazilian Journal of Implantology and Health Sciences 2.3 (2020): 96-109.
Paraguassu, Eber Coelho. "COVID-19, a relação direta entre o capital, solidariedade e as vidas." Brazilian Journal of Implantology and Health Sciences 2.3 (2020): 01-04.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Karina Figueira